TIA – Cardioembolic Pattern — SCE Neurology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Repeat the full first-dose cardiac monitoring procedure when fingolimod is reintroduced
Explanation lettering: D = shown as A · A = shown as C · E = shown as D · C = shown as E
E is correct: after more than one month of treatment, an interruption longer than two weeks can restore the first-dose bradycardic and conduction effects, so first-dose monitoring must be repeated on reintroduction. A ignores the restart rule. B and C are not authorised mitigation strategies. D turns a monitoring requirement into a permanent contraindication. The timing threshold varies earlier in treatment, which is why duration on treatment is specified.
Reference: Gilenya 0.25 mg hard capsules SmPC: https://www.medicines.org.uk/emc/product/4545/smpc